Hinweis-Modus ist eingeschaltet Ausschalten

FTXH - First Trust Nasdaq Pharmaceuticals ETF (USD) (US33738R8372)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

Alle auswählen Alle zurücksetzen
 
(%)
US33738R8372
FTXH ISIN
Exchange Traded Funds (ETF)
Fondstyp
First Trust
Anbieter
40,14 USD
NAV pro Aktie | 10/08/2026
20/09/2016
Startdatum
4 Wiederholungen pro Jahr
Ausschüttung von Dividenden
CEOXMX
CFI
FTXH
Ticker
Formed
Status
Equity
Investitionsobjekt
Healthcare
Sektor
USA
Geographie
Nasdaq US Smart Pharmaceuticals Index
Benchmark
0.6 %
Gesamtkostenquote
37,89 Mio. USD
Gesamtes Fondsvermögen | 15/07/2026
Nein
UCITS

Rendite auf 10/08/2026, NASDAQ

  • YTD
    1,9 %
  • 1M
    -3,36 %
  • 3M
    -4,14 %
  • 6M
    6,24 %
  • 1J
    35,3 %
  • 3J
    33,95 %
  • 5J
    36,59 %
  • 10J
    -
Zum Börsenpreis einschliesslich Einkommenszahlungen

Letzte Daten zum
Zum Vergleichen hinzufügen
von
zu
ADD-IN
Cbonds Add-In API
API Anleihen-Daten

Kurse (FTXH)

Entdecken Sie die umfangreichste Datenbank

1 000 000

Anleihen weltweit

100 000

Aktien

175 910

ETF & Funds

100 000

Indizes

Verwalten Sie Ihr Portfolio auf effizienteste Weise

  • Bond-Screener
  • Watchlist
  • Excel-Add-In
Zugang erhalten

Kurs-Dynamik

FTXH profile

The First Trust Nasdaq Pharmaceuticals ETF (USD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Healthcare sector located in USA. The First Trust fund’s base currency is USD and the share class was registered 20.09.2016 with unique ISIN - US33738R8372. Main exchange is NASDAQ and ticker symbol is FTXH. The total expense ratio is 0.6%. The First Trust Nasdaq Pharmaceuticals ETF (USD) pays dividends 4 time(s) per year.

Struktur FTXH auf 10/08/2026

Struktur in Excel herunterladen
Wertpapier Wertpapier
Eli Lilly and Company 7,61%
AbbVie Inc. 6,97%
Merck & Co., Inc. 6,89%
Johnson & Johnson 6,87%
Bristol-Myers Squibb Company 6,78%
Viatris Inc. 3,56%
Biogen Inc. 3,52%
Amgen Inc. 3,51%
Vertex Pharmaceuticals Incorporated 3,44%
Cardinal Health, Inc. 3,38%
Regeneron Pharmaceuticals, Inc. 3,38%
Pfizer Inc. 3,19%
Gilead Sciences, Inc. 2,91%
United Therapeutics Corporation 2,56%
Jazz Pharmaceuticals Plc 2,53%
Incyte Corporation 2,45%
Illumina, Inc. 2,07%
Zoetis Inc. 1,86%
Charles River Laboratories International, Inc. 1,74%
Exelixis, Inc. 1,61%
Medpace Holdings, Inc. 1,53%
Halozyme Therapeutics, Inc. 1,52%
BioMarin Pharmaceutical Inc. 1,28%
Neurocrine Biosciences, Inc. 1,28%
Alkermes Plc 1,22%
PTC Therapeutics, Inc. 1,2%
Twist Bioscience Corporation 1,19%
10X Genomics, Inc. (Class A) 1,14%
Spyre Therapeutics, Inc. 1,1%
Travere Therapeutics, Inc. 0,92%
Guardant Health, Inc. 0,8%
Protagonist Therapeutics, Inc. 0,73%
TG Therapeutics, Inc. 0,73%
Elanco Animal Health Incorporated 0,72%
Amneal Pharmaceuticals, Inc. 0,69%
Arrowhead Pharmaceuticals, Inc. 0,68%
Ligand Pharmaceuticals Inc. (Class B) 0,66%
Arcus Biosciences, Inc. 0,63%
Roivant Sciences Ltd. 0,55%
ACADIA Pharmaceuticals Inc. 0,54%
Krystal Biotech, Inc. 0,54%
Kymera Therapeutics, Inc. 0,54%
Moderna, Inc. 0,5%
Mirum Pharmaceuticals, Inc. 0,48%
Arcutis Biotherapeutics, Inc. 0,43%
Tarsus Pharmaceuticals, Inc. 0,4%
Supernus Pharmaceuticals, Inc. 0,38%
Ionis Pharmaceuticals, Inc. 0,31%
Alnylam Pharmaceuticals, Inc. 0,29%
US Dollar 0,15%
Alle anzeigen Verstecken
Andere - %

Andere ETFs und Fonds dieses Anbieters

Ähnliche Etf & Fonds

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} Mio.
    NAV
    {{ item.expense_ratio }}
    Gesamtkostenquote
Sie müssen sich registrieren , um Zugriff zu erhalten.